213 related articles for article (PubMed ID: 35804355)
1. Tumor-induced osteomalacia characterized by "painful knee joint with difficulty in moving": a case report.
Jiang L; Tan QQ; Gao CL; Xu L; Zhu JH; Yan PJ; Miao Y; Wan Q; Xu Y
BMC Endocr Disord; 2022 Jul; 22(1):174. PubMed ID: 35804355
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
Ni HJ; Clifton-Bligh R; Brzozowska MM
Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
[No Abstract] [Full Text] [Related]
3. Comparison of
Yu HN; Liu L; Chen QS; He Q; Li YS; Wang Y; Gao S
Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632
[TBL] [Abstract][Full Text] [Related]
4. Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia.
Long T; Hou J; Yang N; Zhou M; Li Y; Li J; Tang Y; Chen D; Hu S
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4202-e4209. PubMed ID: 33864458
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Induced Osteomalacia Localized and Excised After Pregnancy.
Sum M; Hoda ST; Rapp T; Zan E
AACE Clin Case Rep; 2021; 7(6):363-366. PubMed ID: 34765732
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of tumor-induced osteomalacia: a single center experience.
Hacisahinogullari H; Tekin S; Tanrikulu S; Saribeyliler G; Yalin GY; Bilgic B; Isik EG; Salduz A; Tuncer S; Gul N; Uzum AK; Aral F; Tanakol R; Selcukbiricik OS
Endocrine; 2023 Nov; 82(2):427-434. PubMed ID: 37480497
[TBL] [Abstract][Full Text] [Related]
8. Tumor-induced osteomalacia: experience from a South American academic center.
González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
[TBL] [Abstract][Full Text] [Related]
9. Reports of 17 Chinese patients with tumor-induced osteomalacia.
Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
Agrawal K; Bhadada S; Mittal BR; Shukla J; Sood A; Bhattacharya A; Bhansali A
Clin Nucl Med; 2015 Jan; 40(1):e6-e10. PubMed ID: 24999675
[TBL] [Abstract][Full Text] [Related]
11. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.
Clifton-Bligh RJ; Hofman MS; Duncan E; Sim IeW; Darnell D; Clarkson A; Wong T; Walsh JP; Gill AJ; Ebeling PR; Hicks RJ
J Clin Endocrinol Metab; 2013 Feb; 98(2):687-94. PubMed ID: 23295468
[TBL] [Abstract][Full Text] [Related]
12. 68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia.
Zhang J; Zhu Z; Zhong D; Dang Y; Xing H; Du Y; Jing H; Qiao Z; Xing X; Zhuang H; Li F
Clin Nucl Med; 2015 Aug; 40(8):642-6. PubMed ID: 26053726
[TBL] [Abstract][Full Text] [Related]
13. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.
Breer S; Brunkhorst T; Beil FT; Peldschus K; Heiland M; Klutmann S; Barvencik F; Zustin J; Gratz KF; Amling M
Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333
[TBL] [Abstract][Full Text] [Related]
14. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
15. [Tumor localization and treatment of tumor-induced osteomalacia].
Beil FT; Stürznickel J; Rolvien T; Amling M; Oheim R
Z Rheumatol; 2022 Apr; 81(3):182-188. PubMed ID: 35103802
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of
Kato A; Nakamoto Y; Ishimori T; Hayakawa N; Ueda M; Temma T; Sano K; Shimizu Y; Saga T; Togashi K
Ann Nucl Med; 2021 Mar; 35(3):397-405. PubMed ID: 33582980
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
[TBL] [Abstract][Full Text] [Related]
19. A case of hyperparathyroidism secondary to tumor-induced osteomalacia.
Yang Y; Jin P; Zhang S; Chen K; He H; Mo Z; Yuan J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1937-1944. PubMed ID: 38448388
[TBL] [Abstract][Full Text] [Related]
20. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
